Home
Centre for Cancer Biomarkers CCBIO

Research groups

Across the different core programs, several areas of research and specific projects have been initiated at CCBIO, focusing on mechanisms of tumor-microenvironment interactions and tumor progress, discovery and validation of tumor biomarkers, and clinical studies.

CCBIO first principal investigators, from the start in 2013. From the left: Bjørn Tore Gjertsen, James B. Lorens, Karl H. Kalland, Anne Chr. Johannessen, Lars A. Akslen, Rolf K. Reed, the late Helga B. Salvesen, Oddbjørn Straume, Donald Gullberg.
Photo:
Tove Lise Mossestad

CCBIO has 4 research teams and programs:

Team 1: Mechanisms of Tumor-Microenvironment Interactions (Preclinical Studies)

Team 2: Exploration and Validation of Cancer Biomarkers (Biomarker Validation)

Team 3: Clinical Applications and Trial Studies (Clinical Studies)

Team 4: Health Ethics, Prioritization and Economics

  • CCBIO PI Roger Strand (ethics)   PubMed publications
  • CCBIO Associate Investigator John Cairns (health economics)
  • CCBIO Associate Investigator Ole Frithjof Norheim (prioritization)

In addition, Bioinformatics is an important intersecting research area at CCBIO: